Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Interventions

Specimen Handling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Breast Adenocarcinoma × Clear all
NCT04517838 2025-12-24

Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast Cancer

Mayo Clinic

Recruiting
230 enrolled
Breast

Breast Adenocarcinoma

NCT05447910 2025-06-15

Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer

Mayo Clinic

Terminated
21 enrolled
Breast

Breast Adenocarcinoma

NCT06805084 2025-02-03

H/ACA-ER

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Active not recruiting
80 enrolled
Breast

Breast Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡